标题
Sigma receptors and neurological disorders
作者
关键词
-
出版物
Pharmacological Reports
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-08-05
DOI
10.1007/s43440-021-00310-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Sigma-1 receptor agonists as potential protective therapies in multiple sclerosis
- (2020) Robert P. Lisak et al. JOURNAL OF NEUROIMMUNOLOGY
- Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [18F] fluspidine and [18F] fallypride PET study
- (2020) Igor D. Grachev et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Sigma-1 Receptor Activation Induces Autophagy and Increases Proteostasis Capacity In Vitro and In Vivo
- (2019) Maximilian Christ et al. Cells
- Targeting the Sigma-1 Receptor via Pridopidine Ameliorates Central Features of ALS Pathology in a SOD1G93A Model
- (2019) Ariel Ionescu et al. Cell Death & Disease
- Pridopidine Induces Functional Neurorestoration Via the Sigma-1 Receptor in a Mouse Model of Parkinson’s Disease
- (2019) Veronica Francardo et al. Neurotherapeutics
- Neuroprotection in non-transgenic and transgenic mouse models of Alzheimer's disease by positive modulation of σ1 receptors
- (2019) Tangui Maurice et al. PHARMACOLOGICAL RESEARCH
- Safety and Efficacy of Edonerpic Maleate for Patients With Mild to Moderate Alzheimer Disease
- (2019) Lon S. Schneider et al. JAMA Neurology
- Pridopidine protects neurons from mutant-huntingtin toxicity via the sigma-1 receptor
- (2019) Chelsy R. Eddings et al. NEUROBIOLOGY OF DISEASE
- Neuronal Sigma-1 Receptors: Signaling Functions and Protective Roles in Neurodegenerative Diseases
- (2019) Daniel A. Ryskamp et al. Frontiers in Neuroscience
- Small-Molecule Modulators of Sigma1 and Sigma2/TMEM97 in the Context of Cancer: Foundational Concepts and Emerging Themes
- (2019) Halley M. Oyer et al. Frontiers in Pharmacology
- Amyloid-β Peptides are Generated in Mitochondria-Associated Endoplasmic Reticulum Membranes
- (2018) Bernadette Schreiner et al. JOURNAL OF ALZHEIMERS DISEASE
- Protective effect of a novel sigma-1 receptor agonist is associated with reduced endoplasmic reticulum stress in stroke male mice
- (2018) Ryuta Morihara et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Sigma-1 receptor and amyotrophic lateral sclerosis
- (2018) Eduardo E. Benarroch NEUROLOGY
- Sigma-1 Receptor-Modulated Neuroinflammation in Neurological Diseases
- (2018) Jia Jia et al. Frontiers in Cellular Neuroscience
- Pridopidine, a clinic-ready compound, reduces 3,4-dihydroxyphenylalanine-induced dyskinesia in Parkinsonian macaques
- (2018) Tom H. Johnston et al. MOVEMENT DISORDERS
- Cholinesterase inhibitor rivastigmine enhances nerve growth factor-induced neurite outgrowth in PC12 cells via sigma-1 and sigma-2 receptors
- (2018) Kazuki Terada et al. PLoS One
- Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study
- (2018) Ralf Reilmann et al. LANCET NEUROLOGY
- Pridopidine stabilizes mushroom spines in mouse models of Alzheimer's disease by acting on the sigma-1 receptor
- (2018) Daniel Ryskamp et al. NEUROBIOLOGY OF DISEASE
- Small molecule modulator of sigma 2 receptor is neuroprotective and reduces cognitive deficits and neuroinflammation in experimental models of Alzheimer's disease
- (2017) Bitna Yi et al. JOURNAL OF NEUROCHEMISTRY
- The Sigma-1 Receptor Antagonist, S1RA, Reduces Stroke Damage, Ameliorates Post-Stroke Neurological Deficits and Suppresses the Overexpression of MMP-9
- (2017) Pilar Sánchez-Blázquez et al. MOLECULAR NEUROBIOLOGY
- Sigma-1 receptor knockout increases α-synuclein aggregation and phosphorylation with loss of dopaminergic neurons in substantia nigra
- (2017) Juan Hong et al. NEUROBIOLOGY OF AGING
- The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease
- (2017) Daniel Ryskamp et al. NEUROBIOLOGY OF DISEASE
- Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial
- (2017) Richard Smith et al. Neurotherapeutics
- Protection by sigma-1 receptor agonists is synergic with donepezil, but not with memantine, in a mouse model of amyloid-induced memory impairments
- (2016) Tangui Maurice BEHAVIOURAL BRAIN RESEARCH
- The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems
- (2016) Tsung-Ping Su et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Sigma-1 receptor is a molecular target for novel neuroprotectant T-817MA
- (2015) Takeaki Yano et al. Alzheimers & Dementia
- Dysfunction in endoplasmic reticulum-mitochondria crosstalk underlies SIGMAR1 loss of function mediated motor neuron degeneration
- (2015) Nathalie Bernard-Marissal et al. BRAIN
- Allosteric modulation of sigma-1 receptors elicits anti-seizure activities
- (2015) Lin Guo et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia
- (2015) Jeffrey L. Cummings et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pridopidine, a dopamine stabilizer, improves motor performance and shows neuroprotective effects in Huntington disease R6/2 mouse model
- (2015) Ferdinando Squitieri et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Role of the Sigma-1 receptor in Amyotrophic Lateral Sclerosis (ALS)
- (2015) Timur A. Mavlyutov et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Sigma-1 receptor is involved in degradation of intranuclear inclusions in a cellular model of Huntington's disease
- (2015) Yasuo Miki et al. NEUROBIOLOGY OF DISEASE
- Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease
- (2015) Brent J. Ryan et al. TRENDS IN BIOCHEMICAL SCIENCES
- Mitochondrial protection by the mixed muscarinic/σ1 ligand ANAVEX2-73, a tetrahydrofuran derivative, in Aβ25–35 peptide-injected mice, a nontransgenic Alzheimer’s disease model
- (2015) Valentine Lahmy et al. Frontiers in Cellular Neuroscience
- Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism
- (2014) Veronica Francardo et al. BRAIN
- Effects of dextromethorphan on glial cell function: Proliferation, maturation, and protection from cytotoxic molecules
- (2014) Robert P. Lisak et al. GLIA
- Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity
- (2014) Nicholas J. Izzo et al. PLoS One
- Phase II Trial of the Sigma-1 Receptor Agonist Cutamesine (SA4503) for Recovery Enhancement After Acute Ischemic Stroke
- (2014) Roman Urfer et al. STROKE
- Population-Level Evidence for an Autoimmune Etiology of Epilepsy
- (2014) Mei-Sing Ong et al. JAMA Neurology
- A randomized, double-blind, placebo-controlled trial of pridopidine in Huntington's disease
- (2013) MOVEMENT DISORDERS
- Accumulation of the sigma-1 receptor is common to neuronal nuclear inclusions in various neurodegenerative diseases
- (2013) Yasuo Miki et al. NEUROPATHOLOGY
- SA4503, a sigma-1 receptor agonist, suppresses motor neuron damage in in vitro and in vivo amyotrophic lateral sclerosis models
- (2013) Yoko Ono et al. NEUROSCIENCE LETTERS
- Sigma-1 receptor agonist PRE084 is protective against mutant huntingtin-induced cell degeneration: involvement of calpastatin and the NF-κB pathway
- (2013) A Hyrskyluoto et al. Cell Death & Disease
- The dopamine stabilizers ACR16 and (−)-OSU6162 display nanomolar affinities at the σ-1 receptor
- (2012) K Sahlholm et al. MOLECULAR PSYCHIATRY
- Association between a variant of the sigma-1 receptor gene and Alzheimer's disease
- (2012) Ágnes Fehér et al. NEUROSCIENCE LETTERS
- Sigma-1R Agonist Improves Motor Function and Motoneuron Survival in ALS Mice
- (2012) Renzo Mancuso et al. Neurotherapeutics
- Sigma-1 receptor chaperone and brain-derived neurotrophic factor: Emerging links between cardiovascular disease and depression
- (2012) Kenji Hashimoto PROGRESS IN NEUROBIOLOGY
- The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke
- (2011) Karsten Ruscher et al. BRAIN
- Regional Cerebral Glucose Metabolism After Pridopidine (ACR16) Treatment in Patients With Huntington Disease
- (2011) Mouna Esmaeilzadeh et al. CLINICAL NEUROPHARMACOLOGY
- Genetic Polymorphisms in Sigma-1 Receptor and Apolipoprotein E Interact to Influence the Severity of Alzheimers Disease
- (2011) Yue Huang et al. Current Alzheimer Research
- Effects of the selective sigma receptor ligand, 1-(2-phenethyl)piperidine oxalate (AC927), on the behavioral and toxic effects of cocaine
- (2011) Rae R. Matsumoto et al. DRUG AND ALCOHOL DEPENDENCE
- Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial
- (2011) Justo Garcia de Yebenes et al. LANCET NEUROLOGY
- Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cord
- (2011) Olga V. Chechneva et al. NEUROBIOLOGY OF DISEASE
- Efficacy and Safety of the Dopaminergic Stabilizer Pridopidine (ACR16) in Patients With Huntington's Disease
- (2010) Anders Lundin et al. CLINICAL NEUROPHARMACOLOGY
- Early development of sigma-receptor ligands
- (2010) Sanju Narayanan et al. Future Medicinal Chemistry
- Role of Presenilins in Neuronal Calcium Homeostasis
- (2010) H. Zhang et al. JOURNAL OF NEUROSCIENCE
- The sigma-1 receptor is enriched in postsynaptic sites of C-terminals in mouse motoneurons. An anatomical and behavioral study
- (2010) T.A. Mavlyutov et al. NEUROSCIENCE
- The sigma-1 receptor chaperone as an inter-organelle signaling modulator
- (2010) Tsung-Ping Su et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator
- (2009) D. Fontanilla et al. SCIENCE
- Targeting sigma receptors: novel medication development for drug abuse and addiction
- (2009) Rae R Matsumoto Expert Review of Clinical Pharmacology
- Low density of sigma1 receptors in early Alzheimer’s disease
- (2008) Masahiro Mishina et al. ANNALS OF NUCLEAR MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started